GlassScriptPhysician profile
John K Ellington
NPI 1588795215
$4,924,947.94
in general payments reported to CMS, 2019-2025
50 companies · $715K in 2025
The $715K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $377K · 2020: $437K · 2021: $1.6M · 2022: $379K · 2023: $670K · 2024: $712K · 2025: $715K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.3M · Consulting Fee: $510K · Travel and Lodging: $95K · Acquisitions: $85K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $68K · Food and Beverage: $15K · Education: $8,300 · Gift: $12.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,317,189.10 |
| Consulting Fee | $509,835.74 |
| Travel and Lodging | $94,673.17 |
| Acquisitions | $84,577.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $68,196.70 |
| Food and Beverage | $14,885.39 |
| Education | $8,300.00 |
| Gift | $12.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medshape, INC. | $1,335,360.48 | 2019-2022 | |
| Stryker Corporation | $980,416.97 | 2021-2025 | Easyfuse, Aequalis, Flexband |
| Medline Industries LP | $682,398.66 | 2019-2025 | Medline Industries, INC., Medline, Medline Unite |
| Depuy Synthes Products, INC. | $574,923.44 | 2019-2025 | Hammerlock |
| Arthrex, INC. | $333,316.15 | 2019-2025 | Arthrex |
| Restor3d, INC. | $293,885.73 | 2019-2025 | |
| International Life Sciences | $238,743.31 | 2019-2024 | Flexband |
| Zimmer Biomet Holdings, INC. | $98,010.20 | 2021-2025 | Tapestry, Juggerknotless Soft Anchor |
| Sanara Medtech INC. | $92,265.75 | 2023-2025 | Celleraterx, Celleraterx, Biasurge |
| Panther Orthopedics, INC. | $44,336.00 | 2019-2022 | |
| Wright Medical Technology, INC. | $42,316.47 | 2019-2020 | |
| Bone Support INC. | $31,353.77 | 2019-2025 | Ceramentbone Void Filler, Cerament G |
| Bioventus LLC | $29,164.55 | 2019-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Activortho, INC. | $25,773.95 | 2020-2022 | |
| Flower Orthopedics Coporation | $14,347.23 | 2024-2025 | Fibula Nail, 4.5mm X 180mm, Titanium, Flex-Thread, Fibula Nail, 3.5mm X 180mm, Titanium, Flex-Thread, Fibula Nail, 4.5mm X 130mm, Titanium, Flex-Thread |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amniox Medical, INC. | $12,721.59 | 2019-2020 | |
| Smith+Nephew, INC. | $11,249.64 | 2019-2024 | Q-Fix, Bone Anchors With Arthroscopic Delivery System |
| Djo, LLC | $10,821.68 | 2021 | |
| Alafair Biosciences, INC. | $10,230.07 | 2025 | Versawrap |
| Linvatec Corporation | $9,577.63 | 2023-2025 | In2bones USA, Colink Plating System, Biobrace 23mm |
| Glw, INC | $7,635.49 | 2024-2025 | Creed Hammerthread |
| In2bones USA, LLC | $7,442.87 | 2020-2022 | |
| Osteoremedies, LLC | $6,977.83 | 2019-2025 | Biowash Surgical Irrigation, Osteoboost Select 5cc, Biobrush |
| Nuvasive Specialized Orthopedics, INC. | $6,750.00 | 2019-2023 | Precice Intramedullary Limb Lengthening System |
| Curvebeam LLC | $6,000.00 | 2020 | |
| Medical Device Business Services, INC. | $3,867.80 | 2019 | |
| Encore Medical, LP | $2,271.98 | 2021 | |
| Orthofix Medical, INC. | $2,155.08 | 2020-2025 | Truelok |
| Embody, INC. | $1,942.36 | 2021-2022 | |
| Graymont Professional Products Ip, LLC | $1,425.00 | 2019 | |
| Caerus Corp. | $1,250.00 | 2019 | |
| Acumed LLC | $1,236.00 | 2019 | |
| Spinesmith Holdings, LLC | $1,200.00 | 2022 | |
| Depuy Synthes Sales INC. | $928.01 | 2019-2025 | Na, Motoband, Vivigen Mis Delivery System |
| Peerless Surgical INC. | $791.25 | 2021-2025 | |
| Avitus Orthopaedics, INC. | $600.00 | 2023 | |
| Ossio INC | $234.48 | 2021-2023 | |
| Paragon 28, INC. | $230.97 | 2025 | Portfolio |
| Kerecis Limited | $175.76 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Trilliant Surgical LLC. | $136.40 | 2022 | |
| Ermi LLC | $107.61 | 2021 | |
| Novastep INC. | $105.90 | 2022 | |
| Davol INC. | $80.09 | 2021 | |
| Parcus Medical, LLC | $67.01 | 2020 | |
| Gramercy Extremity Orthopedics LLC | $48.55 | 2019 | |
| Horizon Therapeutics Plc | $37.40 | 2019 | |
| Heron Therapeutics, INC. | $19.50 | 2021 | |
| Convatec INC. | $17.33 | 2024 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,084.93 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
$1,039,141.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Ellington listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.